Tenaya Therapeutics, Inc.
Key Metrics
- Previous Close
- $0.32
- 52-Week Range
- $0.30 – $1.46
- Market Cap
- $69.95M
- P/E (TTM)
- —
- EPS (TTM)
- -0.48
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 1.28
- PEG Ratio
- —
- Return on Equity
- -148.16%
- Return on Assets
- -55.43%
- Gross Margin
- 100.00%
- Operating Margin
- -2656.89%
- Profit Margin
- 0.00%
- Current Ratio
- 3.78
- Debt/Equity
- 0.05
- Total Debt
- $2.85M
- Free Cash Flow
- $-29.77M
- Revenue Growth
- —
- Earnings Growth
- —
- Enterprise Value
- $6.01M
Market Snapshot
About
Tenaya Therapeutics is a biotechnology company focused on discovering, developing, and delivering curative therapies for heart disease. The company utilizes three distinct therapeutic platforms: gene therapy, cellular regeneration, and precision medicine approaches to address genetic and non-genetic forms of heart failure. Tenaya aims to transform the treatment landscape for patients with serious cardiovascular conditions.